The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery

NCT02728921 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasms
Urogenital Neoplasm
Systemic Inflammatory Response Syndrome
Hypovolemia

Interventions

DRUG: 5% Albumin infusion 30 min
DRUG: 5% Albumin infusion 3 hours

Sponsor

Region Skane